Changeflow GovPing Courts & Legal Embecta Corp cancels Strive Medtech trademark
Priority review Enforcement Amended Final

Embecta Corp cancels Strive Medtech trademark

Favicon for changeflow.com TTAB Proceedings
Filed
Detected
Email

Summary

The USPTO Trademark Trial and Appeal Board (TTAB) granted Cancellation No. 92089505 filed by Embecta Corp against Strive Orthopedics, Inc., cancelling the STRIVE MEDTECH trademark registration. The cancellation was issued on April 6, 2026, with a refund issued under Trademark Rule 2.114(a)(2). Strive Orthopedics must cease all use of the STRIVE MEDTECH mark effective immediately.

What changed

Embecta Corp successfully obtained cancellation of Strive Orthopedics' STRIVE MEDTECH trademark registration at the TTAB. The cancellation order terminates the defendant's trademark rights and requires immediate cessation of mark usage. This administrative enforcement action modifies the intellectual property landscape in the medical technology sector.

For affected parties, the immediate consequence is loss of trademark protection for STRIVE MEDTECH, exposing the defendant to potential infringement claims by Embecta Corp if similar marks are used. Medical device manufacturers and trademark holders should review their brand portfolios to ensure adequate protection and monitor for competing marks in their market segments.

What to do next

  1. Cease all commercial use of the STRIVE MEDTECH mark
  2. Remove the mark from all product labeling, marketing materials, and digital presence
  3. Update trademark records to reflect cancelled status

Archived snapshot

Apr 7, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO TTAB Proceedings

Cancellation: STRIVE MEDTECH

Cancellation TTAB92089505-20260406 Kind: CAN Apr 06, 2026

Abstract

REFUND ISSUED - TRADEMARK RULE 2.114(A)(2)
Plaintiff: Embecta Corp.
Defendant: Strive Orthopedics, Inc.
Mark at issue: STRIVE MEDTECH

Filing Date

2025-09-15

View original document →

Named provisions

Trademark Rule 2.114(a)(2)

Get daily alerts for TTAB Proceedings

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Filed
April 6th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Cancellation No. 92089505
Docket
TTAB92089505

Who this affects

Applies to
Medical device makers Manufacturers Legal professionals
Industry sector
3345 Medical Device Manufacturing
Activity scope
Trademark cancellation Brand protection Trademark prosecution
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when TTAB Proceedings publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!